/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Zivo Bioscience Inc Share Price Today: Live Updates & Key Insights

Zivo Bioscience Inc share price today is $1.1, up -4.35%. The stock opened at $1.2 against the previous close of $1.15, with an intraday high of $1.29 and low of $1.1.

Zivo Bioscience Inc Share Price Chart

style
pb-0

Zivo Bioscience Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Zivo Bioscience Inc Share Price Performance

$1.1 -0.0435(-4.35%) ZIVO at 13 Mar 2026 04:01 PM Biotechnology
Lowest Today 1.1
Highest Today 1.29
Today’s Open 1.2
Prev. Close 1.15
52 Week High 20.00
52 Week Low 6.95
Day’s Range: Low 1.1 High 1.29
52-Week Range: Low 6.95 High 20.00
1 day return -
1 Week return -
1 month return -
3 month return -
6 month return -
1 year return -
3 year return -
5 year return -
10 year return -

Zivo Bioscience Inc Institutional Holdings

CoreCap Advisors, LLC 0.11

Northern Trust Extended Eq Market Idx 0.05

SSgA U.S. Extended Market Index Class I 0.03

Huntington National Bank 0.00

Zivo Bioscience Inc Market Status

Strong Buy: 0

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

Zivo Bioscience Inc Fundamentals

Market Cap 36.94 M

PB Ratio 21.1296

PE Ratio 0.0

Enterprise Value 37.70 M

Total Assets 1.64 M

Volume 56483

Zivo Bioscience Inc Company Financials

Annual Revenue FY23:15850 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:20000 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:20000 0.0M, FY19:null 0.0M

Annual Net worth FY23:-8509432 -8.5M, FY22:-8745293 -8.7M, FY21:-9396647 -9.4M, FY20:-9655783 -9.7M, FY19:-14667982 -14.7M

Quarterly Revenue Q3/2025:65625 0.1M, Q2/2025:53400 0.1M, Q1/2025:0 0.0M, Q3/2024:31500 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:21288 0.0M, Q2/2025:17922 0.0M, Q1/2025:0 0.0M, Q3/2024:9450 0.0M, Q2/2024:0 0.0M

Quarterly Net worth Q3/2025:-1033056 -1.0M, Q2/2025:-1640232 -1.6M, Q1/2025:-4211188 -4.2M, Q3/2024:-2268597 -2.3M, Q2/2024:-8236368 -8.2M

About Zivo Bioscience Inc & investment objective

Company Information ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. It offers poultry gut health, avian influenza, bovine mastitis, canine joint health, human immune modification, human functional food ingredients, algal biomass for human food, and biomass for supporting skin health and anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Troy, Michigan.

Organisation Biotechnology

Employees 7

Industry Biotechnology

CEO Mr. John Bernard Payne

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow